Current guidelines for screening U.S. blood donors for symptoms of COVID-19 and for a history of recent infections are effectively protecting the blood supply from contamination with the new coronavirus, researchers say.
A study published in JAMA suggests that treatment with vitamin C, in addition to thiamine and hydrocortisone, does not improve treatment outcomes in hospitalized patients with sepsis.
A recent study completed by the University of Chicago School of Medicine suggests a key player should be added to protective measures to stay safe and healthy during the Covid-19 pandemic: Vitamin D.
Denmark’s Novo Nordisk is acquiring New Jersey-based Emisphere Technologies in a deal worth about $1.8 billion.
Developing an ‘Inverse Vaccine’ for Type 1 Diabetes Published: July 14, 2020 By Chelsea Weidman Burke BioSpace What do you get when you mix certain immune cells with vitamin D and a disease-provoking molecule? An innovative new vaccine for type 1 diabetes. “We are trying to educate the immune system to teach it what […]
Few nutritional supplements can protect people from developing or dying from cardiovascular disease, and some may actually be harmful, a research review suggests.
A new study found that taking 4,000 international units per day may double the amount of vitamin D in the blood, but it gives most people roughly the same chance of developing blood sugar problems as people who do not take the vitamin.
Older women who take supplements with high doses of vitamins B6 and B12 may be more likely than their counterparts who do not to experience hip fractures, a U.S. study suggests.
Vitamin D supplementation may not improve bone density or prevent fractures and falls in adults, a large new analysis suggests.
A U.S. District Court ruled in favor of Eli Lilly’s patent on its Alimta vitamin regimen and prevented Hospira and Dr. Reddy’s Laboratories from launching generics until the patent expires.